EMMPRIN expression in oral SCC is regulated by FYN kinase. Read more about EMMPRIN expression in oral SCC is regulated by FYN kinase.
Expression of Fyn kinase modulates EMT in oral cancer cells. Read more about Expression of Fyn kinase modulates EMT in oral cancer cells.
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Read more about Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma. Read more about Identification of {alpha}v{beta}6-positive stem cells in oral squamous cell carcinoma.
The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer. Read more about The role of the integrin alpha v beta6 in regulating the epithelial to mesenchymal transition in oral cancer.
EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma. Read more about EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth. Read more about Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1. Read more about Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
Stathmin is overexpressed in malignant mesothelioma. Read more about Stathmin is overexpressed in malignant mesothelioma.
Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway. Read more about Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.
